Sharma et al. [11] proposed a convolutional neural network for cancer classification based on immunohistochemical response and achieved 0.669 accuracy, in which the WSIs of surgical sections were classified as HER2+ tumor, HER2- tumor, or nontumor. This evidence concerns the gene ERBB2 and neoplasm.